CD4 and breast neoplasm: Rag1KO mice that received WT CD4+ T cells were protected from Brca1-deficient breast tumor growth accompanied by the development of low-grade tumors compared with the Rag1KO + TslprKO CD4+ T cell control group (P = 0.0001; Figs. 8 G and S5 H).